Moloney Securities Asset Management LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 16.7% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 7,434 shares of the healthcare conglomerate’s stock after buying an additional 1,065 shares during the period. Moloney Securities Asset Management LLC’s holdings in UnitedHealth Group were worth $1,378,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. State Street Corp boosted its position in shares of UnitedHealth Group by 2.5% in the first quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock worth $7,499,276,000 after buying an additional 1,122,534 shares during the period. Legal & General Group Plc boosted its position in shares of UnitedHealth Group by 5.4% in the first quarter. Legal & General Group Plc now owns 4,954,692 shares of the healthcare conglomerate’s stock worth $812,630,000 after buying an additional 254,545 shares during the period. Harris Associates L P boosted its position in shares of UnitedHealth Group by 0.3% in the first quarter. Harris Associates L P now owns 4,646,307 shares of the healthcare conglomerate’s stock worth $762,041,000 after buying an additional 14,489 shares during the period. UBS Asset Management Americas Inc. boosted its position in shares of UnitedHealth Group by 6.2% in the first quarter. UBS Asset Management Americas Inc. now owns 4,372,898 shares of the healthcare conglomerate’s stock worth $717,199,000 after buying an additional 255,799 shares during the period. Finally, American Century Companies Inc. boosted its position in shares of UnitedHealth Group by 9.0% in the first quarter. American Century Companies Inc. now owns 4,022,002 shares of the healthcare conglomerate’s stock worth $659,649,000 after buying an additional 333,338 shares during the period. 86.21% of the stock is owned by hedge funds and other institutional investors.

Shares of UnitedHealth Group Incorporated (UNH) traded up 0.58% during mid-day trading on Monday, reaching $195.48. 575,972 shares of the company were exchanged. The company’s 50 day moving average price is $191.39 and its 200 day moving average price is $177.02. UnitedHealth Group Incorporated has a 12 month low of $132.39 and a 12 month high of $196.04. The firm has a market capitalization of $189.00 billion, a PE ratio of 23.48 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, topping the Zacks’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The firm had revenue of $50.05 billion during the quarter, compared to analysts’ expectations of $49.97 billion. During the same period in the previous year, the business posted $1.96 earnings per share. The company’s revenue for the quarter was up 7.7% compared to the same quarter last year. Equities analysts anticipate that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th will be given a dividend of $0.75 per share. The ex-dividend date is Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a yield of 1.54%. UnitedHealth Group’s dividend payout ratio (DPR) is 35.13%.

TRADEMARK VIOLATION WARNING: “Moloney Securities Asset Management LLC Has $1.38 Million Stake in UnitedHealth Group Incorporated (UNH)” was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be viewed at https://www.thecerbatgem.com/2017/08/28/moloney-securities-asset-management-llc-has-1-38-million-stake-in-unitedhealth-group-incorporated-unh.html.

A number of research analysts have issued reports on UNH shares. Vetr raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $179.00 target price for the company in a report on Monday, May 15th. UBS AG reaffirmed an “overweight” rating on shares of UnitedHealth Group in a report on Thursday. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $199.00 target price for the company in a report on Tuesday, May 30th. BidaskClub raised shares of UnitedHealth Group from a “buy” rating to a “strong-buy” rating in a report on Saturday, July 8th. Finally, Morgan Stanley increased their target price on shares of UnitedHealth Group from $202.00 to $210.00 and gave the company an “overweight” rating in a report on Wednesday, June 28th. One research analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the stock. UnitedHealth Group has an average rating of “Buy” and an average price target of $203.41.

In other news, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction on Monday, August 21st. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the completion of the sale, the director now owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Gail R. Wilensky sold 5,540 shares of UnitedHealth Group stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total value of $990,219.60. Following the sale, the director now directly owns 60,516 shares of the company’s stock, valued at approximately $10,816,629.84. The disclosure for this sale can be found here. Insiders have sold 30,540 shares of company stock valued at $5,748,970 in the last three months. Insiders own 0.89% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.